The preventive intervention of tanshinone ⅡA on peritoneal fibrosis in a peritoneal dialysis rat model

ZHANG Miao,JIANG Chun-ming,SHAO Qiu-yuan,SUN Cheng,TAO Na-na
DOI: https://doi.org/10.3969/j.issn.1671-6264.2011.06.006
2011-01-01
Abstract:Objective: To investigate the effects of tanshinone ⅡA on peritoneal fibrosis in a peritoneal dialysis(PD) animal model.Methods: Forty rats were randomly divided into four groups as control group,peritoneal dialysis fluid(PDF) containing 4.25% glucose as PDF group,PDF containing 4.25% glucose and 50 mg·L-1 tanshinone ⅡA as low dose tanshinone ⅡA group and 100 mg·L-1 tanshinone ⅡA as high dose tanshinone ⅡA group(n=10 per group).Eight weeks later,the rats were sacrificed and peritoneal tissue samples were collected for analysis.The expression of transforming growth factor-β1(TGF-β1) and connective tissue growth factor(CTGF) in parietal peritoneum was examined by immunohistochemistry.The mRNA and protein expression of TGF-β1 and CTGF in omentum was examined by reverse transcription polymerase chain reaction or Western blotting.Results: Tanshinone ⅡA significantly suppressed submesothelial compact zone thickening and matrix accumulation induced by 4.25% glucose-based PDF.Tanshinone ⅡA also reduced TGF-β1 and CTGF expression in parietal peritoneum as well as in omentum in a dose-dependent manner.Conclusion: Tanshinone ⅡA prevented the progression of peritoneal fibrosis in this rat model.Tanshinone ⅡA may be a novel therapy for peritoneal fibrosis in patients undergoing long-term PD.
What problem does this paper attempt to address?